Corporate Action9 Jul 2026, 07:30 pm
Novelix Pharma Allots 4.575M Shares, Raises ₹11.9 Cr
AI Summary
The Board of Directors of Novelix Pharmaceuticals Ltd, in a meeting on July 9, 2026, approved the allotment of 3,375,000 equity shares to promoter/promoter group upon warrant conversion at ₹20 each, raising ₹5.06 crore. Additionally, 1,200,000 equity shares were allotted to non-promoters via preferential issue at ₹57 each, raising ₹6.84 crore. In total, 4,575,000 new equity shares were allotted, increasing the company's paid-up equity capital from ₹23.90 crore (23,895,000 shares) to ₹27.27 crore (27,270,000 shares).
Key Highlights
- Board approved allotment of 4,575,000 equity shares.
- ₹11.90 crore raised through these allotments.
- 3,375,000 shares allotted to promoters via warrant conversion.
- 1,200,000 shares allotted to non-promoters via preferential issue.
- Paid-up equity capital increased to ₹27.27 crore.
Price Impact
More from TRIMURTHI